Stoke Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell STOK and other ETFs, options, and stocks.About STOK
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver.
CEOIan Frederick Smith
CEOIan Frederick Smith
Employees128
Employees128
HeadquartersBedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded2014
Founded2014
Employees128
Employees128
STOK Key Statistics
Market cap1.29B
Market cap1.29B
Price-Earnings ratio26.91
Price-Earnings ratio26.91
Dividend yield—
Dividend yield—
Average volume927.50K
Average volume927.50K
High today$23.82
High today$23.82
Low today$22.61
Low today$22.61
Open price$22.74
Open price$22.74
Volume840.70K
Volume840.70K
52 Week high$24.60
52 Week high$24.60
52 Week low$5.35
52 Week low$5.35
STOK News
Simply Wall St 4d
Why Stoke Therapeutics Is Up 13.4% After Positive Long-Term Data for Dravet Syndrome TherapyStoke Therapeutics and Biogen recently announced new clinical data for zorevunersen, an investigational therapy for Dravet syndrome, at the 36th International E...
Analyst ratings
91%
of 11 ratingsBuy
90.9%
Hold
9.1%
Sell
0%
People also own
Based on the portfolios of people who own STOK. This list is generated using Robinhood data, and it’s not a recommendation.